Skip to content

News

TendoNova Inks Partnership with AcCELLerated Biologics

March 8, 2023
TendoNova, an emerging leader in micro-invasive sports medicine procedures, is pleased to announce that it has reached an agreement with AcCELLerated Biologics that will significantly expand the sales network for its lead product, the Ocelot™.
READ MORE

TendoNova wins FDA Clearance for Its New Microinvasive Ocelot Surgical Tool

March 23, 2022
TendoNova, an emerging leader in microinvasive sports medicine procedures, is pleased to announce the FDA 510(k) clearance of its new Ocelot surgical tool, which uses an innovative technology for fragmentation or debridement of soft tissue.
READ MORE

NFLPA Invests in TendoNova to Develop Devices that Enable Microinvasive Orthopedic Procedures

June 11, 2020
The NFL Players Association (NFLPA), through its for-profit subsidiary NFL Players Inc., has invested in TendoNova™ Corporation. TendoNova is an Atlanta-based company that develops medical devices that enable microinvasive orthopedic procedures. The company’s initial product,
READ MORE